Orgentec Diagnostika

Mainz, Germany Founded: 2009 • Age: 17 yrs Acquired By Sebia
Diagnostics tools for Autoimmune and Infectious Diseases
Annual revenue - Latest available
Total funding - 3 rounds
Employees - Tracked headcount
Investors 3 Known backers
Products 3 Services tracked
Competitors - Brand Intelligence

About Orgentec Diagnostika

Orgentec Diagnostika is a company based in Mainz (Germany) founded in 2009 was acquired by Sebia in July 2020. Orgentec Diagnostika has completed 1 acquisition, including Corgenix. Orgentec Diagnostika offers products and services including Alegria, ELISA, and Immunfluoreszenz.

  • Headquarter Mainz, Germany
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Orgentec Diagnostika Gmbh
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $392.96 (USD), Grant

    Feb 01, 2017

  • Investors
    Sebia

    & 2 more

  • Employee Count
    Not available
  • Investments & Acquisitions
  • Acquired by
    Sebia

    (Jul 01, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Orgentec Diagnostika

Orgentec Diagnostika offers a comprehensive portfolio of products and services, including Alegria, ELISA, and Immunfluoreszenz.

Product name locked
Category locked
Primary

System for testing autoimmune and infectious diseases in laboratories

Product name locked
Category locked
Locked

Assay method for detecting antibodies in infectious and autoimmune conditions

Product name locked
Category locked
Locked

Fluorescence-based method for identifying disease markers in diagnostics

People of Orgentec Diagnostika

Headcount 50-200
Employee Profiles 4
Employee Profiles
People
Dr. Natalia Kuzmina
Area Manager Eastern Europe & Central Asia
People
Michael Funk
Finance Director

Unlock access to complete

Funding Insights of Orgentec Diagnostika

Investors in Orgentec Diagnostika

Orgentec Diagnostika has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Sebia, European Union and Water Street.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Water Street is engaged in strategic investments in healthcare sectors.
Locked Locked Locked
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Electrophoresis-based in vitro diagnostics products are developed and provided.
Locked Locked Locked
Premium access

Investor details for Orgentec Diagnostika

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Orgentec Diagnostika

Orgentec Diagnostika has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Corgenix.

Investments
Premium access

Investment portfolio details for Orgentec Diagnostika

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Diagnostic tests for vascular diseases are developed and supplied.
Locked Locked 1990 Locked
Premium access

Complete acquisition details for Orgentec Diagnostika

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Orgentec Diagnostika

Premium access

Detailed financials for Orgentec Diagnostika

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Orgentec Diagnostika Comparisons

Orgentec Diagnostika Primary company
Description
Diagnostics tools for Autoimmune and Infectious Diseases
Location
Mainz, Germany
Founded Year
2009
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Orgentec Diagnostika

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Orgentec Diagnostika

Premium access

Detailed competitors of Orgentec Diagnostika

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Orgentec Diagnostika

Premium access

Complete news archive for Orgentec Diagnostika

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Orgentec Diagnostika

Orgentec Diagnostika was founded in 2009 and raised its 1st funding round 5 years after it was founded.

Orgentec Diagnostika is headquartered in Mainz, Germany. It is registered at Mainz, Rhineland-palatinate, Germany.

James Widergren is the current CEO of Orgentec Diagnostika.

ORGENTEC develops, manufactures and markets in-vitro diagnostic products for clinical labs. The company offers more than 200 highly specific ELISA test systems, blot and immunofluorescence tests for the diagnosis of Autoimmune and Infectious Diseases. In addition, the company offers fully automatic analyzer Alegria, stool diagnostic products (Alpha-1-Antitrypsin test, Calprotectin test, lactoferrin test, Stool Extraction medium, Stool Extraction Tubes, and Stool Sample Collector) and 25-OH vitamin D 3 D 2 ELISA test. Its rapid test rheumachec is a lateral flow test that allows detection of combined rheumatoid factors (RF) and autoantibodies against mutated citrullinated vimentin (anti-MCV ) in a whole blood sample.

Orgentec Diagnostika offers Alegria, ELISA, and Immunfluoreszenz.

Orgentec Diagnostika has made 1 acquisition, including Corgenix.

Orgentec Diagnostika has 3 investors. Key investors include Sebia, European Union, and Water Street.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available